(Q43828961)

27 November 2017

title

GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. (English)

1 reference

27 November 2017

3

Thomas Mertens

1 reference

27 November 2017

Osamu Ijichi

1

1 reference

27 November 2017

Detlef Michel

series ordinal

2

1 reference

27 November 2017

Koichiro Miyata

series ordinal

4

1 reference

27 November 2017

Yoshito Eizuru

series ordinal

5

1 reference

27 November 2017

publication date

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

53

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

135-142

1 reference

A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Selective extraction of polyoma DNA from infected mouse cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900202-9

7 January 2021

10.1016/S0166-3542(01)00202-9

Identifiers

DOI

1 reference

27 November 2017

1 reference